Is Dupilumab a chance for patients with moderate to severe atopic dermatitis? Literature review
Introduction: Atopic dermatitis is an inflammatory disease which can significantly affect quality of life of patients. Especially severe forms of this disease are challenging to treat and for a long time forms of treatment have been limited. Because of that- it is crucial to find new ways of treatme...
Saved in:
Main Author: | Paweł Iwańczuk (Author) |
---|---|
Format: | Book |
Published: |
Kazimierz Wielki University,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of dupilumab in moderate and severe atopic dermatitis
by: Stephan Weidinger, et al.
Published: (2023) -
Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
by: Maria Esposito, MD, et al.
Published: (2023) -
Efficacy and safety of dupilumab in adult moderate-to-severe atopic dermatitis: An update narrative literature review
by: Magdalini Kreouzi, et al.
Published: (2022) -
Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate‐to‐severe atopic dermatitis
by: Delphine Staumont‐Sallé, et al.
Published: (2023) -
Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
by: Adrien Mareschal, et al.
Published: (2020)